Neuromuscular diseases encompass a wide range of disorders characterized by progressive muscle weakness and dysfunction, resulting from abnormalities in the ...

The annual treatment cost of spinal muscular atrophy (SMA) in India is expected to come down to just ₹3,000 annually against the current ₹22 lakh-72 lakh after the Delhi High Court’s Monday verdict ...

A rare genetic condition, Spinal Muscular Atrophy (SMA) affects one in 7,000 people in India. It mostly affects children and often leads to infant mortality In a breakthrough for Spinal Muscular ...

Spinal muscle atrophy is classified as type 1, 2, 3 or 4 depending on age of onset. Most cases are progressive — that is, symptoms worsen instead of improving – but in general the later the symptoms ...

In what could be promising news for patients battling spinal muscular atrophy (SMA), the Delhi High Court has refused to allow a suit by Swiss pharma giant Roche seeking to restrain Indian drugmaker ...

progressive muscle atrophy and flail-arm/flail-leg syndrome, as well as familial/genetic forms. We compared both cohorts with regard to clinical parameters including sex, age at disease onset, ...